Immunology and Cutaneous Malignant Melanoma

Sober, Arthur J.

doi:10.1111/j.1365-4362.1976.tb05089.x

Cited by 33 publications

(2 citation statements)

References 64 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A significant proportion of all articles currently published on malignant melanomas deal with some aspects of host‐tumor immunologic interactions or with approaches to immunotherapy. Since these subjects have been recently reviewed (Kopf, 1971, ; Gutterman et al, 1975; Sober, 1976) and since space does not permit elaboration here, they will merely be summarized in this section. Some current conclusions based on the literature follow: A large body of literature has appeared which indicates that human malignant melanomas have specific antigenic components that differ from those of all other normal and cancerous cells.…”

Section: Section 21mentioning

confidence: 99%

Malignant Melanoma: A Review

Kopf

Bart

Rodríguez-Sains

1977

The Journal of Dermatologic Surgery and Oncology

View full text Add to dashboard Cite

Section: Section 21mentioning

confidence: 99%

Malignant Melanoma: A Review

Kopf

Bart

Rodríguez-Sains

1977

The Journal of Dermatologic Surgery and Oncology

View full text Add to dashboard Cite

“…Some well-known clinical observations have raised suspicions that immune phenomena play an important role in malignant melanoma. Although the exact pathophysiologic mechanisms have not been elucidated [50], those findings are the following:…”

Section: Immunotherapymentioning

confidence: 99%

Adjuvant therapy of cutaneous malignant melanoma: A critical review

Koh

Sober

Harmon

et al. 1985

Med. Pediatr. Oncol.

Self Cite

View full text Add to dashboard Cite

show abstract

Allergic hypersensitivity to neomycin. Relationship between patch test reactions and 'use' tests

Prystowsky¹,

Nonomura²,

Allen³

1979

Archives of Dermatology

View full text Add to dashboard Cite

The prevalence of neomycin patch test sensitivity in the general population is approximately 1%. We describe the relationship between positive neomycin patch tests and clinical "use tests" with two antibiotic combinations (Neosporin G cream and Neosporin ointment). The neomycin use test was positive in seven of eight subjects with a strongly positive patch test, and in two of four subjects with a weakly positive patch test. A positive use test usually occurred earlier and was always more intense with the cream base. The use test reactions were usually mild even with continued application of the antigen. Use tests with commercial products may be helpful in evaluating the clinical relevance of positive patch tests.

show abstract

Immunology and Cutaneous Malignant Melanoma

Cited by 33 publications

References 64 publications

Malignant Melanoma: A Review

Malignant Melanoma: A Review

Adjuvant therapy of cutaneous malignant melanoma: A critical review

Allergic hypersensitivity to neomycin. Relationship between patch test reactions and 'use' tests

Contact Info

Product

Resources

About